Phillip G. Febbo Illumina, Inc. (ILMN) insider trading activity

Phillip G. Febbo is SVP Chief Medical Officer of ILLUMINA, INC.. Currently has a direct ownership of 14,786 shares of ILMN, which is worth approximately $2.1 Million. The most recent transaction as insider was on Mar 01, 2023, when has been sold 7,556 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.8K

0% 3M change

0% 12M change

Total Value Held $2.1 Million

Phillip G. Febbo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2023	BUY Grant, award, or other acquisition	-	7,556 Added 33.82%	14,786 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$252,535 $202.84 p/Share	1,245 Reduced 14.69%	7,230 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	3,522 Added 29.36%	8,475 Common Stock
Nov 05 2022	SELL Payment of exercise price or tax liability	$178,312 $217.19 p/Share	821 Reduced 14.22%	4,953 Common Stock
Apr 06 2022	SELL Open market or private sale	$715,700 $360.01 p/Share	1,988 Reduced 25.61%	5,774 Common Stock
Apr 05 2022	SELL Payment of exercise price or tax liability	$47,663 $363.84 p/Share	131 Reduced 1.66%	7,762 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	3,029 Added 27.73%	7,893 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$320,500 $319.86 p/Share	1,002 Reduced 17.08%	4,864 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	-	2,851 Added 32.71%	5,866 Common Stock
Nov 08 2021	SELL Open market or private sale	$406,830 $406.83 p/Share	1,000 Reduced 24.91%	3,015 Common Stock
Nov 05 2021	SELL Payment of exercise price or tax liability	$182,030 $408.14 p/Share	446 Reduced 10.0%	4,015 Common Stock
Jun 11 2021	SELL Open market or private sale	$447,610 $447.61 p/Share	1,000 Reduced 18.31%	4,461 Common Stock
Apr 05 2021	SELL Payment of exercise price or tax liability	$50,375 $384.54 p/Share	131 Reduced 2.34%	5,461 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$718,625 $494.24 p/Share	1,454 Reduced 20.64%	5,592 Common Stock
Feb 17 2021	BUY Exercise of conversion of derivative security	-	3,173 Added 31.05%	7,046 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	350 Added 8.29%	3,873 Common Stock
Feb 09 2021	BUY Grant, award, or other acquisition	-	1,380 Added 28.15%	3,523 Common Stock
Nov 06 2020	SELL Open market or private sale	$48,066 $310.1 p/Share	155 Reduced 6.74%	2,143 Common Stock
Nov 05 2020	SELL Payment of exercise price or tax liability	$59,850 $311.72 p/Share	192 Reduced 7.71%	2,298 Common Stock

Also insider at

VCYT

VERACYTE, INC. Healthcare

Chief Scientific & Med Officer

PGF

Phillip G. Febbo

SVP Chief Medical Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ILMN shares.

Notify only if

Value

Insider Trading

Get notified when an Illumina, Inc. insider buys or sells ILMN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ILLUMINA, INC.

Track Activities on ILMN

Account